Josh Geballe: Turning Yale Innovation into Startups

Howie and Harlan are joined by Josh Geballe, a Yale SOM graduate who serves as managing director of Yale Ventures, Yale’s initiative overseeing the translation of research into impactful new companies. Harlan reports from the debate on AI in medicine; Howie reflects on the FDA’s approval process for an over-the-counter birth control pill. 

Links:

“Iwasaki to Receive Else Kröner Fresenius Prize Supporting Research Into Long COVID and Similar Conditions”

“As Covid Emergency Ends, U.S. Response Shifts to Peacetime Mode”

“ChatGPT - Reshaping medical education and clinical management”

“Performance of ChatGPT on USMLE: Potential for AI-assisted medical education using large language models”

“Artificial Hallucinations in ChatGPT: Implications in Scientific Writing”

Yale Ventures

Tsai Center for Innovative Thinking at Yale

“The economic transformation: What would change in the net-zero transition”

“Joint Meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee May 9, 2023 – May 10, 2023”

FDA | May 9-10, 2023: Joint Meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee Meeting Announcement

“F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill”

Food and Drug Administration | Prescription-to-Nonprescription (Rx-to-OTC) Switches

“Over-the-counter sales of statins and other drugs for asymptomatic conditions”

Learn more about the MBA for Executives program at Yale SOM.

Email Howie and Harlan comments or questions.